Catecholamines can induce pulmonary remodeling in rats

Cell Physiol Biochem. 2012;30(5):1134-47. doi: 10.1159/000343304. Epub 2012 Oct 5.

Abstract

Background/aims: Previously, we found that catecholamine (CA) infusion in rats induced pulmonary injury with edema and inflammation resembling acute lung injury in humans. Here, we examined effects of norepinephrine (NE) and of selective α- and β-adrenergic agonists on the remodeling of pulmonary extracellular matrix.

Methods: Eighty rats were infused over 8-72 h with NE, phenylephrine (PE), isoproterenol (ISO) or NaCl solution. We investigated mRNA expression of collagen, matrix metalloproteinase (MMP)-2, its tissue inhibitor (TIMP-2) and transforming growth factor (TGF)-β isoforms in lung tissue. Additionally, lung histology, hemodynamic function and cardiac hypertrophy were evaluated.

Results: After 72 h of infusion, lung histology showed beginning fibrosis and vascular hypertrophy. Collagen type I, MMP-2 and TIMP-2 mRNA expression were significantly elevated. All these effects were most pronounced with NE while PE and ISO induced weaker responses. TGF-β mRNA expression was also elevated after 72 h, predominantly after PE infusion. Cardiac hypertrophy was most pronounced after ISO infusion.

Conclusion: CA infusion over 72 h may induce pulmonary remodeling. Mainly α-adrenergic but also β-adrenergic mechanisms contribute to these processes. In contrast, cardiac hypertrophy is predominantly mediated by β-adrenergic stimulation and hence, is considered to be a direct adrenergic effect rather than a consequence of pulmonary fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Extracellular Matrix / drug effects*
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / pathology
  • Female
  • Isoproterenol / administration & dosage
  • Isoproterenol / pharmacology*
  • Matrix Metalloproteinase 2 / metabolism
  • Norepinephrine / administration & dosage
  • Norepinephrine / pharmacology*
  • Phenylephrine / administration & dosage
  • Phenylephrine / pharmacology*
  • Pulmonary Fibrosis / chemically induced*
  • Pulmonary Fibrosis / metabolism
  • Pulmonary Fibrosis / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • Transforming Growth Factor beta
  • Tissue Inhibitor of Metalloproteinase-2
  • Phenylephrine
  • Matrix Metalloproteinase 2
  • Isoproterenol
  • Norepinephrine